[{"Assets_0_Q2_USD":"632802000.0","CIK":"1628171","CommonStockSharesIssued_0_Q2_shares":"74462077.0","CommonStockSharesOutstanding_0_Q2_shares":"74462077.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"-0.82","EarningsPerShareBasic_2_Q2_USD":"-1.6","EarningsPerShareDiluted_1_Q2_USD":"-0.82","EarningsPerShareDiluted_2_Q2_USD":"-1.6","Industry":"Specialty Chemicals","Market":"NASDAQ","Market Cap":"1775342076.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"-110876000.0","NetIncomeLoss_1_Q2_USD":"-61222000.0","NetIncomeLoss_2_Q2_USD":"-118869000.0","OfficialName":"Revolution Medicines Inc. Common Stock","ProfitLoss_2_Q2_USD":"-118869000.0","RevenuesConverted_1_Q2_USD":"9116000.0","RevenuesConverted_2_Q2_USD":"16694000.0","SP500":null,"Sector":"Consumer Durables","StockholdersEquity_0_Q2_USD":"498841000.0","Ticker":"RVMD","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"74280590.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"74221803.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"74280590.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"74221803.0","filed":"20220809","footnote":null,"form":"10-Q","fp":"Q2","fy":"2022.0","name":"REVOLUTION MEDICINES, INC.","period":"20220630","qtrs":"0","uom":"USD"}]